Cargando…
Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
Glioblastoma (GBM) is one of the most malignant types of brain cancer. Tumor treating fields (TTFields) is the up-to-date treatment for GBM. However, its molecular mechanism requires additional investigation. Herein, a novel TTFields system was developed (CL-301A) and its efficiency in suppressing G...
Autores principales: | Xu, Shengchao, Luo, Chengke, Chen, Dikang, Tang, Lu, Chen, Ling, Liu, Zhixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388668/ https://www.ncbi.nlm.nih.gov/pubmed/35982032 http://dx.doi.org/10.1038/s41419-022-05127-7 |
Ejemplares similares
-
Correction: Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
por: Xu, Shengchao, et al.
Publicado: (2022) -
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling
por: Xu, Shengchao, et al.
Publicado: (2023) -
Downregulation of CyclophilinA/CD147 Axis Induces Cell Apoptosis and Inhibits Glioma Aggressiveness
por: Xu, Shengchao, et al.
Publicado: (2020) -
A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma
por: Xu, Shengchao, et al.
Publicado: (2020) -
Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2020)